Related Experiment Video

Updated: Aug 6, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis

Pankaj Gupta1, Mark R Walter, Zao-zhong Su

  • 1Department of Pathology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA.

Cancer Research
|August 17, 2006
PubMed

Insights

Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) selectively induces cancer cell death. Researchers identified its interaction with BiP/GRP78, revealing a key mechanism for its anti-tumor activity and potential for new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) is a cytokine with demonstrated anti-cancer properties.
  • Clinical trials show mda-7/IL-24 is safe and effective against various solid tumors and melanomas.
  • The precise molecular mechanisms underlying mda-7/IL-24's tumor-selective action remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular basis of mda-7/IL-24's cancer-selective growth suppression and apoptosis induction.
  • To identify specific domains and intracellular targets of mda-7/IL-24 responsible for its anti-tumor effects.
  • To explore the potential for developing enhanced therapeutic applications of mda-7/IL-24.

Main Methods:

  • Deletion analysis was used to create a functional mutant (M4) of mda-7/IL-24.
  • Rationally designed mutational analysis was employed to investigate protein interactions and cellular localization.
  • Key signaling pathways, including p38 MAPK and GADD gene expression, were assessed.

Main Results:

  • A truncated mutant, M4 (amino acids 104-206), retained the cancer-specific anti-proliferative and pro-apoptotic functions of full-length mda-7/IL-24.
  • MDA-7/IL-24 and M4 were shown to physically interact with BiP/GRP78 via their C and F helices.
  • Both forms of MDA-7/IL-24 localized to the endoplasmic reticulum and activated p38 MAPK and GADD gene expression, leading to cancer-selective apoptosis.

Conclusions:

  • BiP/GRP78 is identified as a specific intracellular target of mda-7/IL-24, mediating its anti-cancer effects.
  • The interaction with BiP/GRP78 and subsequent pathway activation are crucial for the tumor-selective apoptosis induced by mda-7/IL-24.
  • These findings provide mechanistic insights and support the development of novel mda-7/IL-24-based cancer therapeutics.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...